Erie Indemnity

ERIE · NYSE · Financials · United States

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025$3.3B$3.3B$3.8B$3.8B$4.1B$4.1B13.8% margin13.8% marginRevenueNet margin

Quarterly · last 8

Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26$880.7M$880.7M$990.4M$990.4M$999.9M$999.9M$989.4M$989.4M$1.1B$1.1B$1.1B$1.1B$1.0B$1.0B$1.1B$1.1B16.5% margin16.5% marginRevenueNet margin

Revenue (FY2025)

$4.1B

Net margin

13.8%

ROE

24.5%

Revenue CAGR (2y)

+11.5%

Profit CAGR (2y)

+12.0%

Net profit (FY2025)

$559.3M

Ask MarketChacha about ERIE

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

  • Aug 25, 2026

    No specific company catalyst or new filing/news identified for the drop; ERIE moved lower amid broader caution on outlook and rising costs noted after its Q2 beat, consistent with recent underperformance vs peers.

    source 1source 2· confidence: low
  • Aug 4, 2026

    No clear company-specific catalyst identified for the gain; ERIE moved with the broader market or insurance sector.

    · confidence: low
  • Jul 28, 2026

    No specific news or filing explains the move; ERIE rose ahead of its July 30 earnings report amid recent analyst and media commentary highlighting the stock as undervalued.

    · confidence: low
  • Jul 24, 2026

    Erie Indemnity shares rose as the stock traded near record territory, supported by underwriting profits that bolster the valuation.

    source 1· confidence: medium

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

PeriodRevenueNet profitNet marginROE
FY2025$4.1B$559.3M13.8%24.5%
FY2024$3.8B$600.3M15.8%30.2%
FY2023$3.3B$446.1M13.6%26.8%

Quarterly

PeriodRevenueNet profitNet margin
2026Q2$1.1B$180.3M16.5%
2026Q1$1.0B$150.5M14.9%
2025Q3$1.1B$182.9M17.1%
2025Q2$1.1B$174.7M16.5%
2025Q1$989.4M$138.4M14.0%
2024Q3$999.9M$159.8M16.0%
2024Q2$990.4M$163.9M16.5%
2024Q1$880.7M$124.6M14.1%
2023Q3$858.9M$131.0M15.3%
2023Q2$839.9M$117.9M14.0%
2023Q1$752.5M$86.2M11.5%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.